Oxford Instruments PLC
05 August 2026
5 August 2026
Oxford Instruments plc (the "Company")
Director/PDMR shareholding
Notification of transactions of persons discharging managerial responsibility or persons closely associated
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||
|
a) |
Name |
Richard Tyson |
||||||||
|
2 |
Reason for the notification |
|||||||||
|
a) |
Position/status |
Chief Executive Officer and PDMR |
||||||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
|
a) |
Name |
Oxford Instruments plc |
||||||||
|
b) |
LEI |
213800J364EZD6UCE231 |
||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 5p each in Oxford Instruments plc
|
||||||||
|
b) |
Nature of the transaction |
Exercise of 23,501 shares (including 802 dividend shares) per an award granted under the Long Term Incentive Plan 2023 over nominally priced options of £0.05. Sale of 11,124 shares to cover tax and fees with the remaining 12,377 shares transferred to his spouse, Louise Tyson, for nil consideration. |
||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||
|
d) |
Aggregated information - Volume - Price - Total - Volume - Price - Total - Volume - Price - Total |
23,501 £0.05 £1,175.05 11,124 £27.857132 £309,882.74 12,377 £nil £nil |
||||||||
|
e) |
Date of the transaction |
31 July 2026 - Exercise and sale of shares 5 August 2026 - Transfer to spouse |
||||||||
|
f) |
Place of the transaction |
Exercise of award - Outside of a trading venue Sale of shares and transfer to spouse - London Stock Exchange (XLON) |
||||||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||
|
a) |
Name |
Louise Tyson |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Person Closely Associated with a PDMR (Chief Executive Officer) |
||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Oxford Instruments plc |
||||
|
b) |
LEI |
213800J364EZD6UCE231 |
||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 5p each in Oxford Instruments plc
|
||||
|
b) |
Nature of the transaction |
Transfer of shares from spouse, for nil consideration. |
||||
|
c) |
Price(s) and volume(s) |
|
||||
|
d) |
Aggregated information - Volume - Price - Total |
12,377 £nil £nil |
||||
|
e) |
Date of the transaction |
5 August 2026 |
||||
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
||||
Enquiries:
Sarah Harvey
Company Secretary
sarah.harvey@oxinst.com
The Company makes this announcement, including the notifications above, in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.